Liposomal Bupivacaine in Simultaneous Bilateral Total Knee Arthroplasty
The Safety of Liposomal Bupivacaine in Simultaneous Bilateral Total Knee Arthroplasty
Sponsor: OrthoCarolina Research Institute, Inc.
Listed as NCT02349542, this PHASE4 trial focuses on Arthroplasty, Replacement, Knee and Pain and remains completed. Sponsored by OrthoCarolina Research Institute, Inc., it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Sep 2017 — Jun 2018 [monthly]
Completed PHASE4
▶ Show 2 earlier versions
-
Feb 2017 — Sep 2017 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- OrthoCarolina Research Institute, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .